An interventional study of POWERPLAY in Men, Health Behavior and Health Knowledge, Attitudes, Practice, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-08.
Sponsored by University of British Columbia · Not applicable, Interventional, and Prevention
With funding from the Candian Cancer Society, the Men's Healthy Eating Active Living (MHEAL) project began the development, evaluation, and optimization of a program called POWERPLAY to promote men's health at work.
The MHEAL project began November 2013 and a program (called "POWERPLAY") was developed to support men's active living and healthy eating based on a systematic review of the literature and consultations with groups of men. From 2014-2017 six male-dominated worksites in northern BC offered POWERPLAY and participated in this study. Using a quasi-experimental pre-post design as well as interviews with worksite leads, the program was demonstrated to be an effective, feasible, and acceptable approach to the promotion of modifiable behaviours known to reduce the risk of cancer among working men in northern settings, and several manuscripts were published. Furthermore, the POWERPLAY program was optimized based on feedback received to include friendly competitions, weekly motivational messages, men-friendly language/images, and pedometers, and a manual for employers and website were developed (http://www.powerplayatwork.com/). A new module to support mental well-being was created in 2017 based on a systematic review of the literature for men's mental wellness programs, consultations with men working in northern workplaces, and interviews with workplace representatives. A module to support smoking cessation module was created in 2018.
55 studies on the registry are indexed under Multiple Endocrine Neoplasia Type 1; 20 are open to participants now.
This study's enrollment of 227 is above the median of 58 across 39 interventional studies indexed under Multiple Endocrine Neoplasia Type 1.
Browse Multiple Endocrine Neoplasia Type 1 studies →University of British Columbia is the lead sponsor of 1,335 studies on the registry; 255 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Men employed in participating workplaces, full-time or part-time, in any position within the organization
Exclusion Criteria:
Although females were not discouraged from participating in the POWERPLAY program, they were not included in the evaluation.
Powerplay, a workplace wellness program designed for male-dominated work sites, is the intervention. The program focuses on physical activity, healthy eating, mental wellness, and smoking cessation as well as promoting changes in workplace environments to support employee health and wellness. Program delivery is supported with a detailed program manual and web-based resources. More information about the intervention is available here: http://www.powerplayatwork.com/
Behavioral: POWERPLAY
All men from participating worksites are invited to completed surveys prior to and following implementation of a workplace wellness program (called "POWERPLAY")
Physical Activity
Weekly physical activity was assessed using the Godin Leisure-Time Exercise Questionnaire (Godin \& Shephard, 1985).
Time frame: 6 months
Healthy Eating
Self-reported servings of fruits and vegetables
Time frame: 6 months
Ran from Sep 2014 to primary completion in Jun 2019, 57 months.
Of 20 interventional studies with no phase under Multiple Endocrine Neoplasia Type 1, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 57. This study's 57 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Multiple Endocrine Neoplasia Type 1 →
University of British Columbia →